Literature DB >> 3154670

Correction of physiological alterations of hypertension.

E D Frohlich1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3154670     DOI: 10.1007/bf02209074

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


× No keyword cloud information.
  40 in total

1.  Dependence of arterial pressure on intravascular volume in treated hypertensive patients.

Authors:  H P Dustan; R C Tarazi; E L Bravo
Journal:  N Engl J Med       Date:  1972-04-20       Impact factor: 91.245

2.  Plasma volume expansion resulting from interference with adrenergic function in normal man.

Authors:  J V Weil; C A Chidsey
Journal:  Circulation       Date:  1968-01       Impact factor: 29.690

3.  Hemodynamics and other determinants in development of left ventricular hypertrophy.

Authors:  E D Frohlich
Journal:  Fed Proc       Date:  1983-07

4.  Immediate hemodynamic effects of a new calcium-channel blocking agent (nitrendipine) in essential hypertension.

Authors:  H O Ventura; F H Messerli; W Oigman; F G Dunn; E Reisin; E D Frohlich
Journal:  Am J Cardiol       Date:  1983-03-01       Impact factor: 2.778

Review 5.  The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies.

Authors:  T H Hostetter; H G Rennke; B M Brenner
Journal:  Am J Med       Date:  1982-03       Impact factor: 4.965

6.  Treatment of hypertension with nifedipine, a calcium antagonistic agent.

Authors:  M T Olivari; C Bartorelli; A Polese; C Fiorentini; P Moruzzi; M D Guazzi
Journal:  Circulation       Date:  1979-05       Impact factor: 29.690

7.  Hemodynamic factors in the pathogenesis and maintenance of hypertension.

Authors:  E D Frohlich
Journal:  Fed Proc       Date:  1982-06

8.  Cardiovascular effects of verapamil in patients with essential hypertension.

Authors:  R E Schmieder; F H Messerli; G E Garavaglia; B D Nunez
Journal:  Circulation       Date:  1987-05       Impact factor: 29.690

9.  Diltiazem maintains renal vasodilation without hyperfiltration in hypertension: studies in essential hypertension man and the spontaneously hypertensive rat.

Authors:  T Isshiki; C Amodeo; F H Messerli; B L Pegram; E D Frohlich
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

Review 10.  History of calcium antagonists.

Authors:  A Fleckenstein
Journal:  Circ Res       Date:  1983-02       Impact factor: 17.367

View more
  4 in total

Review 1.  Systolic hypertension in the elderly.

Authors:  G H Rutan
Journal:  Cardiovasc Drugs Ther       Date:  1991-01       Impact factor: 3.727

Review 2.  Choosing the correct drug for the individual hypertensive patient.

Authors:  L H Opie
Journal:  Drugs       Date:  1992       Impact factor: 9.546

3.  Immediate and prolonged hemodynamic effects of TA-3090 on spontaneously hypertensive (SHR) and normal Wistar-Kyoto (WKY) rats.

Authors:  T Isshiki; B L Pegram; E D Frohlich
Journal:  Cardiovasc Drugs Ther       Date:  1988-11       Impact factor: 3.727

Review 4.  Calcium channel antagonists. Part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1988-03       Impact factor: 3.727

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.